Search

everythinglearnresearchcommunity

for

Search:↓

Puberty often causes skin issues like acne and excessive sweating, and treatments require patience as results may vary.

Chemotherapy patients don't all lose their hair due to factors like hair growth rates, age, genetics, and the type of drugs used.

Some drugs can cause skin and hair color changes, often reversible when the drug is stopped.

Some thymic peptides can increase human hair growth, while others may inhibit it.

Ocimum oil may promote hair growth and reduce hair loss from cyclophosphamide.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

Ocoxin improves quality of life for advanced ovarian cancer patients on chemotherapy.

Different hair growth problems are caused by genetic issues or changes in hair growth cycles, and new treatments are being developed.

Methotrexate side effects vary by race and sex.

Nurses are exposed to chemotherapy drugs, risking health issues like hair loss, so protective gear and monitoring are needed.

Biodegradable polymers can improve cannabinoid delivery but need more clinical trials.

Microemulsions could improve how drugs are delivered and absorbed in the body.

Accurate diagnosis is key for treating different kinds of hair loss, and immune response variations may affect the condition and treatment results.

The paper suggests that telogen effluvium, a type of hair loss, may be a long-lasting condition triggered by stress or illness in people whose hair growth is unusually synchronized.

A rare skin condition was confirmed to be associated with a specific virus in a young girl.

Azelaic acid treats acne, rosacea, and hyperpigmentation with minimal side effects.

DFMO treatment improves hair growth, muscle tone, and development in Bachmann-Bupp syndrome patients.

The document concludes that permanent hair loss conditions are complex, require early specific treatments, and "secondary permanent alopecias" might be a more accurate term than "secondary cicatricial alopecia."

Alfredo Rebora suggested a new, easier way to classify hair loss in Telogen Effluvium, adding a type possibly related to autoimmune diseases.

Palliative chemotherapy is cost-effective for advanced gastric and colorectal cancer but not clearly for pancreatic-biliary cancer.

Nonantibiotic macrolides show promise for treating various inflammatory skin conditions.

Scarring alopecias are complex hair loss disorders that require early treatment to prevent permanent hair loss.

No method fully prevents hair loss from chemotherapy, but some methods can reduce it and improve quality of life.

A child on life support experienced rapid hair loss due to severe illness affecting hair growth.

TGF-β is crucial for controlling stem cell behavior and changes in its signaling can lead to diseases like cancer.

pH, calcium, and reactive oxygen species regulate plant cell growth, with key roles for NADPH oxidases and plasma membrane H+-ATPases.

Green tea extract helps prevent cell death and supports cell survival in hair cells exposed to a chemotherapy drug.

New treatments for psoriasis have improved effectiveness and may reduce long-term side effects when combined with standard therapies.

Bimatoprost helps with hair growth and eye conditions but can be costly and have side effects.

The conclusion is that we need more effective hair loss treatments than the current ones, and these could include new drugs, gene and stem cell therapy, hormones, and scalp cooling, but they all need thorough safety testing.